Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuraxis (NRXS) Research & Development (2022 - 2025)

Historic Research & Development for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $130850.0.

  • Neuraxis' Research & Development rose 364.6% to $130850.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $160644.0, marking a year-over-year decrease of 1264.98%. This contributed to the annual value of $206107.0 for FY2024, which is 2172.99% up from last year.
  • As of Q3 2025, Neuraxis' Research & Development stood at $130850.0, which was up 364.6% from $58319.0 recorded in Q2 2025.
  • Neuraxis' 5-year Research & Development high stood at $130850.0 for Q3 2025, and its period low was -$89081.0 during Q4 2024.
  • Moreover, its 4-year median value for Research & Development was $56315.5 (2024), whereas its average is $49807.1.
  • As far as peak fluctuations go, Neuraxis' Research & Development tumbled by 391085.1% in 2024, and later surged by 98718.13% in 2025.
  • Quarter analysis of 4 years shows Neuraxis' Research & Development stood at $81371.0 in 2022, then crashed by 102.73% to -$2221.0 in 2023, then crashed by 3910.85% to -$89081.0 in 2024, then skyrocketed by 246.89% to $130850.0 in 2025.
  • Its Research & Development was $130850.0 in Q3 2025, compared to $58319.0 in Q2 2025 and $60556.0 in Q1 2025.